Clinical study of Cephapirin (a Cephalosporin antibiotic for injection) applied to the oral and maxillo-facial infections and prevention of post-operative infections.
スポンサーリンク
概要
- 論文の詳細を見る
Evaluating the clinical validity of Cephapirin (Cefatrexyl for injection), which is known as an effective antibiotic mainly applied to gram-positive bacilli, we administered it to 5 patients who suffered from oral and maxillo-facial infection and to 16 patients for preventing post-operative infection. These cases were admitted and treated at our department between November 1984 and May 1985. Then the following results were obtained<BR>1) Cefapirin was administered from 2 to 6 g by intravenous injection twice a day, for 3 to 19 days with an average of 6 days.<BR>2) Researched cases were composed of 21 patients (12 men and 9 women) whose ages ranging from 14 to 76 years.<BR>3) The efficacy rate of the drug was 80% in the group of infection such as severe acute osteomyelitis or phlegmone.<BR>4) The efficacy rate was 100% in the group that using to preventing post-operative infections, after operations such as excision of tumor or cyst, or open reduction of jaw fructures.<BR>5) Side effects were observed in 3 cases (14%), which were recorded as drug eruption, diarrhea and others. Various clinical examinations were performed in 10 cases, but any abnormal finding was not recognized during and after administration of Cefapirin.<BR>As conclusion of this evaluation, it could be emphasized that Cefapirin was an useful antibiotic for primary severe infections and preventing post-operative infections in the oral and maxillo-facial regions.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果